Washington, Sept 26 : Researchers at the Swedish medical university Karolinska Institutet (KI) and the Swedish Institute for Infectious Disease Control (SMI) say that they have identified specific parts of the adhesive protein produced by the malaria parasite, which can lead to the development of a vaccine for the disease in future.
Led by Professor Mats Wahlgren at the Department of Microbiology, Tumour and Cell Biology at KI, a team of researchers studied the adhesive protein PfEMP1 in children with severe malaria.
London, Sept 26 : A new study has revealed that women with advanced breast cancer can live longer by taking the drug Herceptin, even after they have suffered a relapse.
The finding is based on data from the Hermine trial, an observational study involving 340 women with advanced HER2-positive breast cancer.
Herceptin is the only HER2-targeted therapy proven to extend lives in both early and advanced stages of the disease.
Washington, Sept 26 : According to a study focused on non-mass enhancing breast lesions, Proton magnetic resonance spectroscopy (¹H MRS) used in conjunction with magnetic resonance imaging (MRI) can aid radiologists in diagnosing breast cancer while reducing the number of false-positive results and invasive biopsies.
The study, conducted at Memorial Sloan-Kettering Cancer Centre in New York, is published in the October issue of the journal Radiology.
Washington, September 26 : An ophthalmologist at Weill Cornell Medical College has said that restoring vision to cataract patients may be possible by implanting them with the newly developed multi-focal lenses.
“There are no alternatives to surgery, but there are new advances to the restoration process. We have lenses that will allow you to see at a distance as well as read without glasses. There are lenses that can correct astigmatisms. The options have become much-improved in the past couple of years,” said Dr. Calvin Roberts.